跳至主要内容
临床试验/CTRI/2024/11/076984
CTRI/2024/11/076984尚未招募不适用

Assessing the role of neuroimaging connectomes and neuropsychological profiles in predicting cognitive decline in late-life depression: A prospective study

ICMR DHR Young Medical Faculty Ph.D. program 20241 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年1月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
150
试验地点
1
主要终点
Cognitive Decline

研究概览

简要总结

Summary

Background: Dementia is a syndrome typically caused by progressive cognitive decline in neurodegenerative diseases resulting in impairment of activities of daily living. There is a substantial economic burden at family and community level. The Longitudinal Aging Study in India (LASI) estimated dementia prevalence for adults ages 60+ in India is 7.4%. A systematic review and meta-analysis estimated the pooled prevalence of depression among the elderly population in India to be approximately 34.4%. The 2020 Lancet commission on Dementia lists 12 modifiable risk factors that together account for 40% of dementias worldwide and theoretically they could be prevented or delayed. LLD accounts for 4% of the risk. Late-life depression is associated with cognitive impairments that may persist even after successful treatment of depressive symptoms, potentially serving as an early indicator or prodrome of dementia.  LLD is considered both a risk factor and prodrome of Dementia, but the link between LLD and Dementia has not been fully elucidated. Not all patients with LLD progress into Dementia. While there is a well-established association between late-life depression and increased dementia risk, the causal pathways remain unclear. It is not clear as to which clinical and neuropsychological profile of patients develop Dementia. Dementia and late-life depression LLD both involve significant alterations in brain networks, which are linked to their symptoms and progression. Neuroimaging offers several advantages as a biomarker for dementia. Human Connectome Project (HCP), Alzheimer’s Disease Neuroimaging Initiative (ADNI) and Alzheimer’s Disease Connectome Project (ADCP) are ongoing connectome based projects looking at neuroimaging as a biomarker for AD. To the best of our knowledge, non of the studies looked at comparing connectomes of LLD which is considered a risk factor/prodrome with that of Dementia. In this study we intend to fill this gap thereby facilitating early diagnosis and treatment initiation for Dementia.

Novelty: To build neuroimaging connectome datasets for Late Life Depression (LLD), Dementia and healthy controls for our population. Many studies have looked at neuropsychological profiles and single MRI sequence to explore the correlation between LLD and Dementia. This study looks at multimodal imaging which will allow us to build a predictive model for cognitive decline in LLD with more accuracy. To the best of our knowledge this is the first study from India exploring the connection between LLD and Dementia through multimodal imaging.

Methods and procedure: A prospective study of persons with LLD(n=35) with comparison groups of Dementia(n=35) and healthy controls(n=35). Connectomes are built using multimodal neuroimaging ( T1,T2,FLAIR,DWI,DTI,ASL and rsfMRI) sequences and neuropsychological assessments are carried out at 6 month and 12 month time points. A predictive model for cognitive decline in LLD will be built using the neuroimaging, neuropsychological and clinical data.

Outcome: Datasets for LLD, Dementia and healthy population. A predictive model that’ll inform us about which LLD patients are more likely to develop cognitive decline. This helps in early diagnosis and treatment planning Dementia. Having these datasets for our population will nurture future research in the field.

Keywords: Late Life Depression, Dementia, Connectome, Datasets, Predictive model

Problem Statement

LLD is considered both a risk factor and prodrome of Dementia, but the link between LLD and Dementia has not been fully elucidated. Not all patients with LLD progress into Dementia. It is not clear as to which clinical and neuropsychological profile of patients develop Dementia. Though many prospective studies have established the temporal association of LLD and Dementia, the known biomarkers didn’t yield conclusive evidence for the same. Neuroimaging findings are one of the biomarkers that will inform us about the risk of progression to Dementia. Till now many prospective studies have looked at individual sequences and techniques of neuroimaging to establish a link between LLD and Dementia and identified patterns similar to both the conditions. But there is lot of inconsistency due to multiple factors like symptom heterogeneity, lack of experimental rigor, individual marker/ imaging technique etc. Use of multimodal neuroimaging techniques, each having its own strengths yields more comprehensive understanding of brain abnormalities, pathology, and their relationship to clinical symptoms.

Hypothesis/ Research question: This study hypothesizes that Late life depression (LLD) and Dementia share more underlying structural and functional changes in the brain than previously understood. We intend to investigate this overlap by creating connectomes using advanced neuroimaging techniques and study specific patterns of connectome that will predict the cognitive decline in LLD patients.

The research question: How do neuroimaging connectomes in LDD and Dementia patients overlap and differ and can specific connectome patterns in LLD patients predict the extent of cognitive decline at one year follow-up?

研究设计

研究类型
Observational

入排标准

年龄范围
60.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Group with Late life Depression- Persons meeting criteria for Major depressive disorder according to DSM 5 diagnostic guidelines Group with Dementia-Persons meeting criteria for Major neurocognitive disorder of mild severity according to DSM 5 diagnostic guidelines Group with Healthy volunteers- Persons without a diagnosis of Major depressive disorder and Major neurocognitive disorder.

排除标准

  • Group with Late life Depression-Persons with diagnosis of a preexisting psychiatric or neurological illness Group with Dementia-Persons with diagnosis of Major cognitive disorder due to Traumatic brain injury, Infective/Substance related etiology and those with early onset dementia Group with Healthy volunteers-Persons with diagnosis of a preexisting psychiatric or neurological illness.

结局指标

主要结局

Cognitive Decline

时间窗: Intake and 1 year follow up

次要结局

  • Neuroimaging connectome(Baseline)

研究者

发起方
ICMR DHR Young Medical Faculty Ph.D. program 2024
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Shalini Perugu

St.Johns Medical College

研究点 (1)

Loading locations...

相似试验